Ryouhei Uehara
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus.
Journal: Internal medicine (Tokyo, Japan)
Published: November 02, 2020
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease.
Journal: Biomedical reports
Published: October 16, 2020
Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 13, 2019
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease.
Journal: Biomedical reports
Published: June 14, 2019
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection.
Journal: Internal medicine (Tokyo, Japan)
Published: January 11, 2019
Hepatitis C virus-related symptoms, but not quality of life, were improved by treatment with direct-acting antivirals.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 17, 2017
Evaluation of surgical resection for gallbladder carcinoma at a Japanese cancer institute.
Journal: Hepato-gastroenterology
Published: July 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026